Pegasus expands Pharma team with senior hires
March 11, 2019 |
Five new recruits support further growth of the Pharma & Life Sciences team
From top left: Ed Sexton, Holly Willmott, Adam Pett. From bottom left: Riana Horner, Jen Lewis
Following continued portfolio growth throughout 2018, Pegasus, an Ashfield Company, part of UDG Healthcare plc, has bolstered its Pharma & Life Sciences practice with the appointment of five new team members in recent weeks.
The new recruits bring additional sector expertise and further strengthen the agency’s integrated communications offering.
James Osborn, Director, Pharma & Life Sciences at Pegasus, said: “The expansion of our team follows a year of significant, consistent growth. I’m delighted to welcome our newest recruits and look forward to working alongside them. Their experience and spirit will enable us to create even more inspirational campaigns that help improve people’s lives.”
The hires include Adam Pett, Senior Account Director, who brings 20 years of marketing communications experience to Pegasus. He has delivered brand and advertising campaigns for a range of clients including Roche, UK Stem Cell Foundation and Department of Health, as well as BBC Worldwide, Procter & Gamble and Amazon.
Jen Lewis joins Pegasus as an Account Director from precision oncology company Agendia, where she was Director of Strategic Marketing and Communications EMEA. Jen has over 10 years’ experience in agency and in-house medical communications.
Account Director, Ed Sexton, previously led media relations for the UK BioIndustry Association, whose award-winning Brexit campaign represented more than 330 life sciences companies in the UK. A journalist by training, Ed has a strong track record in corporate and policy-based communications.
Additionally, Riana Horner joins as Account Manager with cross-sector social and digital marketing expertise from her previous role at Space Digital (Australia). Senior Account Executive, Holly Wilmott, arrives from health agency Creative Connection.
Pegasus recently won silver at the PM Society Awards for its innovative ‘reverse poem’ that marked twenty years of progress in HIV treatment. The recognition follows the agency winning the Charity Challenge Award at the 2018 PharmaTimes Communications Team of the Year 2018 and being ‘Highly Commended’ for Consultancy of the Year at last year’s Communique Awards.
Pegasus’ recruitment drive in Pharma & Life Sciences continues this month, with newly created roles including Senior Account Manager. To learn more about life at Pegasus and career opportunities in the Pharma & Life Sciences team visit: http://thisispegasus.co.uk/vacancies/ or email careers@thisispegasus.co.uk
ENDS
For more information about Pegasus, supporting imagery, or to arrange an interview, please contact Kate Gerrard on +44(0) 1273 712 102 / kate.gerrard@thisispegasus.co.uk
Notes to editors
About Pegasus
Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching campaigns across industries and channels in a health first, sector second approach. Our 140 specialists span earned and owned channels, technologies, and audiences ranging from consumers to healthcare professionals. And, as part of Ashfield Healthcare Communications, we have a global footprint across 32 countries and every conceivable therapy and service area. Being plugged in to this wider network means we’re able to provide end-to-end solutions to healthcare organisations across the world. For more information, go to www.thisispegasus.co.uk
About Ashfield Healthcare Communications
Ashfield Healthcare Communications, part of UDG Healthcare plc, provides global solutions for clients, adding value through unique insights and tailored, scientifically rigorous, multichannel, healthcare communications offerings. Its mission is to improve lives by helping healthcare professionals and patients get the medicines, knowledge, and support they need. Ashfield Healthcare Communications’ multichannel and specialist agencies include ACUMED, Ashfield Digital & Creative, Ashfield Healthcare Communications K.K., BlueMomentum, Cambridge BioMarketing, CircleScience, Clinical Bridges, CodonMedical, CreateNYC, FireKite, Galliard, Gardiner-Caldwell Communications, GeoMed, iMed Comms, Infusion, InterPhase Consult, Nyxeon, Pegasus, Physicians World Europe, QXV Comms, Scientific Connexions, Seren Communications, StemScientific, Watermeadow Medical and Zoetic Science. For more information, go to www.ashfieldhealthcarecommunications.com
This content was provided by Inizio
Company Details
Latest Content from Inizio
Inizio Engage CEO Jim Sage featured in pharmaphorum’s “12 Questions” series
Discover Jim Sage’s insights on leadership, industry challenges, and the transformative impact of data, technology, and patient-centric innovation in his latest pharmaphorum “12 Questions” interview.
Reframing the Obesity Conversation: Key Takeaways from ObesityWeek® 2025
As the understanding of obesity continues to evolve, so too does the science, patient experience, and cross-sector collaboration driving innovation. At ObesityWeek® 2025 in Atlanta, experts from across Inizio reflected...
How DataGateway unified oncology data for real-world insights & market intelligence
Discover how our DataGateway platform unifies fragmented real-world oncology data into a single, validated dataset that delivers deeper insights and faster decision-making.
Inizio launches InConcert™ to transform pre-launch planning through connected intelligence.
Inizio today announced the launch of InConcert™, a new AI-powered data solution designed to accelerate smarter, evidence-led decisions during the critical pre-launch phase of the product lifecycle.
ESMO 2025 highlights: How storytelling, design & emotion are transforming scientific engagement
Discover key insights from ESMO 2025 on how design, emotion, and sustainability are reshaping medical congress experiences. Featuring expert takes from Inizio leaders.
Preparing for ASH 2025: Pharma’s role in hematology innovation
As the global hematology community prepares for the 67th ASH® Annual Meeting and Exposition, Inizio experts share their perspectives on what’s driving the field forward – and how pharma companies...
AI without limits: A smarter, integrated approach to Medical Affairs
At Inizio Medical, we believe AI isn’t replacing Medical Affairs — it’s redefining what’s possible. Our platform, iON.AI™, enhances human expertise, streamlines complex workflows, and strengthens strategic impact through seamless...
What to expect from Obesity Week 2025: Key trends shaping the future of obesity care
Discover how Inizio experts are shaping the future of obesity care—where science, strategy, and innovation unite to advance cardiometabolic health and drive real-world impact.
AI with intent: How Inizio is redefining pharma through precision and partnership
At Fierce Pharma Week, Inizio revealed how the fusion of human expertise and purposeful AI is reshaping pharma communications and driving real-world impact—discover how this human-centered innovation is defining the...
Leading the future of Intelligent Commercialization™: Where proprietary data, tech, and AI meet expert insight
Inizio is leading the way in Intelligent Commercialization™ by uniting proprietary AI-powered platforms, deep scientific expertise, and proven governance to unlock measurable, lasting value at every stage of commercialization.